Precision medicine

Biobanks are vital to research and diagnostics, but we still have a lot of work to do...

When it comes to investigating death, we must first ask ourselves, “What is the question?”

New collaborative guidelines for molecular biomarker testing in colorectal cancer

Two experts explain why they believe ctDNA analysis is the future of cancer pathology

To win the war on cancer, we need to put proteomics on an equal footing with genomics

Chiral amino acids are now under the spotlight as biomarkers for kidney disease

New biomarkers could predict cognitive decline in Parkinson's disease patients

Ultrasensitive mutation analysis could boost the potential of liquid biopsy

Circulating tumor DNA profiling can yield new insights into early-stage lung cancer evolution

Metabolomic biomarker detection strategies must take a new direction to succeed